VIDD News
Search and Filter
Results per Page:
New bacterium named in honor of Fred Hutch
First organism named after research center linked to bacterial vaginosis, higher HIV risk
There’s no crystal ball for modeling the pandemic
Mathematical modelers explain challenges, limitations of their work to predict COVID-19 outcomes
Community engagement in HIV trials guides equity for COVID-19 vaccine studies
New study highlights longstanding barriers to diversity in prior decade of vaccine trials, despite federal guidelines
Could bacterial enzymes drive cancer formation by directly modifying human DNA?
W.M. Keck Foundation grant will help scientists pioneer new technologies to find out
HIV antibody trial results offer 'proof of concept'
Outcome of AMP shows feasibility of developing potent antibody combinations to block HIV
Cancer patients and the COVID-19 vaccines
Clinicians, cancer patients and coronavirus researchers weigh in on vaccination safety, timing, allergy concerns and more
Scientists predict progress against COVID-19, cancer in 2021
After a challenging and deadly 2020, some hopeful predictions for the new year
A year of research dominated by the coronavirus
Scientists applied diverse expertise to pandemic in 2020 while advancing discoveries and cures for cancer
Vaccines stop COVID-19 symptoms, but do they stop transmission?
Researchers mull options, including college dorm studies and 'human challenge' trials, to find answer
HIV vaccine trials are complicated by the availability of PrEP
World AIDS Day 2020: Vaccine researchers still find ways to run trials amid growing use of HIV-prevention drugs
Fearless Science is ...
Hutch researchers take bold approaches to solving hard problems
Biostatistician Dr. Deborah Donnell named AAAS Fellow
Honor recognizes her key role in HIV prevention studies
Celebrate safely: Scientists offer advice, urge vigilance during holidays
'Now is the time for delayed gratification' — so skip big gatherings and travel to prevent the spread of COVID-19
From the freezers, a speedier way to evaluate antiviral drugs
Lookback research showed today’s ‘viral load’ measurements and machine learning quickly mirrored outcomes of older, slower trials
New regional collaborations will accelerate innovation in data-intensive medical science
Three research teams in Washington, Oregon and British Columbia receive pilot funding from Cascadia Data Alliance
No flu yet, but still — get your shot
COVID-19 pandemic makes prevention measures against influenza all the more important
Scientists map structure of potent antibody against coronavirus
Computer-generated images show why immune protein neutralizes SARS-CoV-2
Dr. Anna Wald lauded by Infectious Diseases Society
Virologist will deliver prestigious John F. Enders Lecture during annual conference
Fred Hutch opens COVID-19 Clinical Research Center
Medical director outlines goals for the new facility that will host two treatment trials right away
Imperfect, widely used measures best option against COVID-19, argues Dr. Joshua Schiffer
We need tests, masks, treatments and vaccines to be widespread, not perfect, says infectious disease expert in New York Times editorial